{"id":7988,"date":"2021-09-03T14:46:30","date_gmt":"2021-09-03T14:46:30","guid":{"rendered":"http:\/\/cvx.vc\/?p=7988"},"modified":"2021-09-03T14:46:30","modified_gmt":"2021-09-03T14:46:30","slug":"cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen","status":"publish","type":"post","link":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/","title":{"rendered":"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen"},"content":{"rendered":"<p><em>*Hvis du er interesseret i at v\u00e6re en del af syndikatinvesteringen eller vil h\u00f8re mere om StatuManu ICP, s\u00e5 kontakt venligst til Investment Manager, S\u00f8ren Lund, p\u00e5 <a href=\"mailto:soren@cvx.vc\"><strong>soren@cvx.vc<\/strong><\/a>*<\/em><\/p>\n<p>Efter at have hentet en afg\u00f8rende certificering g\u00e5r CVX Ventures nu sammen med StatuManu ICP (herefter StatuManu) om en investeringsrunde p\u00e5 15-20 mio. kr. CVX Ventures danner et syndikat med en r\u00e6kke MedTech-eksperter i spidsen, som skal st\u00f8tte StatuManu mod det kommercielle gennembrud. Derudover investerer den nuv\u00e6rende ejerkreds, som bl.a. best\u00e5r af Ulrik Spork, tidligere Managing Partner i Novo Holdings, Thomas Dam, kundedirekt\u00f8r i Saxo Bank og Peter K\u00fcrstein, bestyrelsesmedlem i bl.a. Radiometer, FOSS og Bavarian Nordic, yderligere ind i selskabet.<\/p>\n<p><em>\u201cStatuManu er f\u00f8rst og fremmest interessant, fordi de har skabt et produkt der kan \u00e6ndre hele proceduren inden for m\u00e5ling af trykforhold i hjernen og dermed l\u00f8se et enormt problem. Nu skal de have kloge penge som skal bidrage til markedsentr\u00e9en og udbredelse af teknologien. Den nuv\u00e6rende ejerkreds foretager en stor investering ind i runden ved siden af os, og det er et utroligt st\u00e6rkt signal om troen p\u00e5 StatuManus globale potentiale,\u201d<\/em> forklarer S\u00f8ren Lund, Investment Manager i CVX Ventures.<\/p>\n<p>StatuManu blev stiftet i 2015 af iv\u00e6rks\u00e6tterene Jakob Find Madsen og Klavs Fischer Hansen, med henblik p\u00e5 at redde liv. Gennem en patenteret teknologi l\u00f8ser StatuManu et veldefineret klinisk behov via detektering af intrakranielle trykforhold, uden at skulle bore i kraniet. Dermed fjerner man alle risici der er forbundet ved den nuv\u00e6rende metode og kan foretage flere tests og opdage diagnoser i tide.<\/p>\n<p><em>\u201cStatuManu har udviklet et produkt, som i bund og grund kan redde liv, prim\u00e6rt ved at lette og forbedre triageringen af akut syge og sv\u00e6rt tilskadekomne patienter. Med nutidens teknik kan trykket i hovedet kun m\u00e5les efter indf\u00f8rsel af en trykm\u00e5ler i hjernen gennem et borehul i kraniet. Eftersom det alene kan foreg\u00e5 p\u00e5 en neurokirurgisk afdeling, kan det forsinke diagnostocering og dermed relevant behandling. StatuManus teknologi kan med sin lette anvendelighed og uden behov for kirurgi revolutionere hele feltet og bringe trykm\u00e5ling i hjernen helt til skadestedet,&#8221;<\/em> forklarer Frantz Rom Poulsen, Professor i Neurokirugi ved Odense Universitetshospital.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MedTech-virksomheden StatuManu ICP forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.<\/p>\n","protected":false},"author":25,"featured_media":8022,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[18],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.4 (Yoast SEO v23.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen | CVX Ventures<\/title>\n<meta name=\"description\" content=\"MedTech-virksomheden StatuManu ICP forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen\" \/>\n<meta property=\"og:description\" content=\"MedTech-virksomheden StatuManu ICP forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/\" \/>\n<meta property=\"og:site_name\" content=\"CVX Ventures\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cvxventures\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-03T14:46:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"472\" \/>\n\t<meta property=\"og:image:height\" content=\"265\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kim Jessica Axholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Jessica Axholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/\"},\"author\":{\"name\":\"Kim Jessica Axholt\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\"},\"headline\":\"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen\",\"datePublished\":\"2021-09-03T14:46:30+00:00\",\"dateModified\":\"2021-09-03T14:46:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/\"},\"wordCount\":393,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg\",\"articleSection\":[\"Blogindl\u00e6g\"],\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/\",\"url\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/\",\"name\":\"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen | CVX Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg\",\"datePublished\":\"2021-09-03T14:46:30+00:00\",\"dateModified\":\"2021-09-03T14:46:30+00:00\",\"description\":\"MedTech-virksomheden StatuManu ICP forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#primaryimage\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg\",\"width\":472,\"height\":265},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\/\/cvx.vc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvx.vc\/da\/#website\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"name\":\"CVX Ventures\",\"description\":\"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder\",\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvx.vc\/da\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cvx.vc\/da\/#organization\",\"name\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"width\":827,\"height\":394,\"caption\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/cvxventures\/\",\"https:\/\/www.linkedin.com\/company\/cvxventures\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\",\"name\":\"Kim Jessica Axholt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"caption\":\"Kim Jessica Axholt\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen | CVX Ventures","description":"MedTech-virksomheden StatuManu ICP forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/","og_locale":"da_DK","og_type":"article","og_title":"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen","og_description":"MedTech-virksomheden StatuManu ICP forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.","og_url":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/","og_site_name":"CVX Ventures","article_publisher":"https:\/\/www.facebook.com\/cvxventures\/","article_published_time":"2021-09-03T14:46:30+00:00","og_image":[{"width":472,"height":265,"url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg","type":"image\/jpeg"}],"author":"Kim Jessica Axholt","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"Kim Jessica Axholt","Estimeret l\u00e6setid":"2 minutter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#article","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/"},"author":{"name":"Kim Jessica Axholt","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb"},"headline":"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen","datePublished":"2021-09-03T14:46:30+00:00","dateModified":"2021-09-03T14:46:30+00:00","mainEntityOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/"},"wordCount":393,"commentCount":0,"publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg","articleSection":["Blogindl\u00e6g"],"inLanguage":"da-DK","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/","url":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/","name":"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen | CVX Ventures","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#primaryimage"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg","datePublished":"2021-09-03T14:46:30+00:00","dateModified":"2021-09-03T14:46:30+00:00","description":"MedTech-virksomheden StatuManu ICP forbereder i \u00f8jeblikket en investering i millionklassen i samarbejde med CVX Ventures. Nu skal syndikatet fyldes op med de sidste investorer.","breadcrumb":{"@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#primaryimage","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/09\/StatuManu.jpg","width":472,"height":265},{"@type":"BreadcrumbList","@id":"https:\/\/cvx.vc\/da\/insights\/cvx-ventures-og-statumanu-gar-sammen-om-investering-i-millionklassen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/cvx.vc\/"},{"@type":"ListItem","position":2,"name":"CVX Ventures og StatuManu ICP g\u00e5r sammen om investering i millionklassen"}]},{"@type":"WebSite","@id":"https:\/\/cvx.vc\/da\/#website","url":"https:\/\/cvx.vc\/da\/","name":"CVX Ventures","description":"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder","publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvx.vc\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/cvx.vc\/da\/#organization","name":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor","url":"https:\/\/cvx.vc\/da\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","width":827,"height":394,"caption":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor"},"image":{"@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cvxventures\/","https:\/\/www.linkedin.com\/company\/cvxventures\/"]},{"@type":"Person","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb","name":"Kim Jessica Axholt","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","caption":"Kim Jessica Axholt"}}]}},"_links":{"self":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/7988"}],"collection":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/comments?post=7988"}],"version-history":[{"count":0,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/7988\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media\/8022"}],"wp:attachment":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media?parent=7988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/categories?post=7988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/tags?post=7988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}